# Ibuprofen

## Pedea inj 10mg/2mL (專案進口)

| TAH Drug Code      | [**IPEDE**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPEDE)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of Patent Ductus Arteriosus (PDA) in premature neonates (>34 weeks' gestational age)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | Micromedex: Patent ductus arteriosus (PDA): 10 mg/kg/dose IV followed by 5 mg/kg at 24 and 48 hours after treatment initiation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | for Pedea: untreated infection, bleeding, thrombocytopenia; coagulation defects, necrotizing enterocolitis, renal impairment, congenital heart disease if patency of the ductus arteriosus is necessary for pulmonary or systemic blood flow (e.g., pulmonary atresia, severe tetralogy of Fallot, severe coarctation of the aorta).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | For Pedea sepsis, anemia, bleeding, apnea, adverse GI effects, renal impairment, respiratory tract infection, dermatologic effects, hypoglycemia, hypocalcemia, respiratory failure. Cardiovascular: Hypotension (intravenous, up to 10% ) Dermatologic: Rash (oral, 3% to 9% ) Endocrine metabolic: Hypernatremia (intravenous, up to 10% ), Hypoalbuminemia (intravenous, 3% to 10% ), Hypoproteinemia (intravenous, up to 13% ), Serum lactate dehydrogenase level elevated (intravenous, 3% to 10% ) Gastrointestinal: Flatulence (injection, 7% to 16% ), Heartburn (oral, 3% to 9% ), Nausea (oral, 3% to 9%; intravenous, 53% to 57% ), Vomiting (oral, 1% to 3%; intravenous, 15% to 22% ) Hematologic: Thrombocytosis (intravenous, 3% to 10% ) Immunologic: Bacteremia (injection, 13% ) Neurologic: Dizziness (oral, 3% to 9%; intravenous 4% to 6% ), Headache (oral, 1% to 3%; intravenous, 9% to 11% ) Renal: Serum blood urea nitrogen raised (intravenous, up to 10% ), Urinary retention (intravenous, 3% to 5% ) Respiratory: Bacterial pneumonia (intravenous, 3% to 10% ) |
| Pregnancy          | Human Data Suggest Risk in 1st and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## Idofen 20mg/mL, 120mL suspension

| TAH Drug Code      | [**LIDO1**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=LIDO1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Relief of pain, inflammation & fever.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | Children: Antipyretic: For children aged 6 months to 12 years old, if the body temperature is lower than 102.5 °F (about 39.2 ° C), the recommended dose is 0.25 mL/kg; if the body temperature is 102.5 ° F (about 39.2 ° C) or higher, the recommended dose is 0.5 mL/kg. The duration is generally maintained for 6 to 8 hours. maximum dose: 2 mL/kg/day. Analgesic: For children from 6 months to 12 years of age to relieve mild to moderate pain, the recommended dose is 0.5 mL/kg Q6H-Q8H. maximum daily dose: 2 mL/kg/day Juvenile arthritis: 1.5-2 mL/kg/day in 3-4 divided doses. Children with mild symptoms 1 mL/kg/day. Adults: Antipyretic:20mL q4h-q6h. Primary menstrual pain:20mL q4h Rheumatoid arthritis and osteoarthritis, chronic diseases including sudden symptoms :60 mL-160 mL per day (15 mL QID; 20 mL-40 mL, TID-QID) |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Peptic ulceration; patients in whom attacks of asthma, angioedema, urticaria or rhinitis are precipitated by aspirin & other NSAIDs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | GI effects including ulceration; rashes; bronchospasm. Rarely, thrombocytopenia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Pregnancy          | Human Data Suggest Risk in 1st and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

